Lawrence Baruch, MD

Articles by Lawrence Baruch, MD

Ezetimibe 5 and 10 mg for Lowering LDL-C: Potential Billion-Dollar Savings With Improved Tolerability

ByLawrence Baruch, MD,Bhanu Gupta, MD,Sharon S. Lieberman-Blum, PharmD,Sanjay Agarwal, MD,Calvin Eng, MD

October 15th 2008

This retrospective study strongly suggests that splitting a 10-mg ezetimibe tablet yields a 5-mg dose that is clinically equivalent to the 10-mg dose.

Latest Updated Articles

Ezetimibe 5 and 10 mg for Lowering LDL-C: Potential Billion-Dollar Savings With Improved Tolerability
Published: October 15th 2008 | Updated:

Lawrence Baruch, MD

Articles by Lawrence Baruch, MD

Ezetimibe 5 and 10 mg for Lowering LDL-C: Potential Billion-Dollar Savings With Improved Tolerability

Latest Updated Articles

Trending on AJMC

Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD

GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms

FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause

Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD

Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies